According to Ascopiave's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 15.5798. At the end of 2023 the company had a P/E ratio of 13.5.
Year | P/E ratio | Change |
---|---|---|
2023 | 13.5 | -15.06% |
2022 | 15.9 | -4.47% |
2021 | 16.6 | 23.78% |
2020 | 13.4 | 676.32% |
2019 | 1.73 | -88.83% |
2018 | 15.5 | -7.48% |
2017 | 16.7 | 47.98% |
2016 | 11.3 | 0.4% |
2015 | 11.3 | -1.36% |
2014 | 11.4 | 10.88% |
2013 | 10.3 | -3.65% |
2012 | 10.7 | -84.18% |
2011 | 67.6 | 457.2% |
2010 | 12.1 | -3.4% |
2009 | 12.6 | -31.93% |
2008 | 18.4 | -1.35% |
2007 | 18.7 | -8.02% |
2006 | 20.3 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.